Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linzess (ASP0456) Phase 2 in IBS-C
NCT01714843Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Aug 2012
- Primary completion
- Dec 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of linaclotide in irritable bowel syndrome (IBS), sponsored by Astellas Pharma. Started Aug 2012; status: completed.
02
Drugs
linaclotide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01714843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01714843.